BASF hopes to get more than $2B in sales from biotech crops

08/4/2009 | Bloomberg

BASF said it expects to gain more than $2 billion in annual sales from biotech crops developed under its joint venture with Monsanto. A company spokeswoman said BASF will make its plant biotechnology unit an operating division by 2011 or 2012 once its new products reach the market.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA